Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
blinatumomab
blinatumomab
- Restricted Anti-Neoplastic Formulary
- Restricted Blincyto --> Restricted to oncology and admin approval.
Last updated: Nov. 28, 2025
- Black Box Warning: Cytokine Release Syndrome and Neurological Toxities
- HAZ-MED: Table 2H
Blincyto medication guide
Formulary restricted to oncologist use in the hospital outpatient in a bed status for MRD-Positive B-Cell Precursor ALL and B-Cell Precursor ALL in the Consolidation Phase.
If requested for an inpatient, submit to pharmacy administration for case by case evaluation.
Reviewed: April 28, 2015, October 2025
Blincyto 10.2025 Update.pdf